0001213900-24-003937.txt : 20240117 0001213900-24-003937.hdr.sgml : 20240117 20240117102122 ACCESSION NUMBER: 0001213900-24-003937 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240117 EFFECTIVENESS DATE: 20240117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Precise Bio, Inc. CENTRAL INDEX KEY: 0001904090 ORGANIZATION NAME: IRS NUMBER: 474571992 STATE OF INCORPORATION: DE FISCAL YEAR END: 1221 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-502616 FILM NUMBER: 24537056 BUSINESS ADDRESS: STREET 1: 111 NORTH CHESTNUT STREET, SUITE 103 CITY: WINSTON-SALEM STATE: NC ZIP: 27101-4054 BUSINESS PHONE: 336.955.1120 MAIL ADDRESS: STREET 1: 111 NORTH CHESTNUT STREET, SUITE 103 CITY: WINSTON-SALEM STATE: NC ZIP: 27101-4054 D 1 primary_doc.xml X0708 D LIVE 0001904090 Precise Bio, Inc. 111 NORTH CHESTNUT STREET, SUITE 103 WINSTON-SALEM NC NORTH CAROLINA 27101-4054 336.955.1120 DELAWARE None None Corporation true Aryeh Batt 1 Ha-Ganan Street Modi'in Macabim Reut L3 ISRAEL 7169524 Executive Officer Director Promoter Avi Katz 111 North Chestnut Street, Suite 103 Winston-Salem NC NORTH CAROLINA 27101-4054 Director Anthony Atala 111 North Chestnut Street, Suite 103 Winston-Salem NC NORTH CAROLINA 27101-4054 Director Promoter Shay Soker 111 North Chestnut Street, Suite 103 Winston-Salem NC NORTH CAROLINA 27101-4054 Director Promoter Ilan Lior 1 Ha-Ganan Street Modi'in Macabim Reut L3 ISRAEL 7169524 Director Ori Hadimi 1 Ha-Ganan Street Modi'in Macabim Reut L3 ISRAEL 7169524 Executive Officer Director Nathan Cali 150 East Palmetto Park Rd., Suite 110 Boca Raton FL FLORIDA 33432 Director Dirk Muehlhoff Carl Zeiss Meditec AG ZEISS Group Carl-Zeiss-Promenade 10 Jena 2M GERMANY 07745 Director Viko Dana 1 Ha-Ganan Street Modi'in Macabim Reut L3 ISRAEL 7169524 Director Biotechnology Decline to Disclose 06b false 2022-07-14 true true false 75000 Michael Avruch None None None 3800 EUCLID AVE APT 113, CLEVELAND OH OHIO 44115 FL FLORIDA NC NORTH CAROLINA true 25000000 12000000 13000000 false 8 75000 true 0 Commissions are in form of warrants. 700000 true The gross proceeds are being used to fund development and other operating expenses. The payments described in this Item 16 include compensation payments to the executive officers and directors named in Item 3, above. false Precise Bio, Inc. /S/ EYAL ARIELI EYAL ARIELI CFO 2024-01-16